IDNA: iShares Genomics Immunology and Healthcare ETF

Performance

IDNA +47.62%

Watchlist

Select an item

RETURNS1DYTD1Y5Y Ann.Max DDSharpeDiv. Yield
IDNA-0.93%+47.32%+47.62%-3.32%-12.98%1.290.73%

Summary

IDNA at a glance

IDNA returned +47.62% over the past year and -3.32% a year over five years. Its worst drop in that year was -12.98%, smaller than 43% of ETFs on Redstone, and its Sharpe ratio of 1.29 beats 94% of ETFs on Redstone. It yields 0.73%.

Current Drawdown

-12.98%

Rolling Volatility

40.26%

Dividends

IDNA dividends

Yield

0.73%

Paid, past year

$0.28

Pays

Twice a year

Growth a year

+60.3%

Per share, by year

2023
$0.12
2024
$0.22
2025
$0.31
Past year
$0.28

Yearly return over 5 years

With dividends-3.32%
Price only-4.23%
From dividends+0.91 pts

IDNA paid $0.28 a share over the past year, twice a year. Its yearly rate rose from $0.12 in 2023 to $0.31 in 2025, 60.3% a year. With dividends reinvested it returned -3.32% a year over five years, against -4.23% on price alone.

›All 9 payments since Dec 13, 2021
  • Jun 15, 2026$0.1254
  • Dec 16, 2025$0.1555
  • Jun 16, 2025$0.1529
  • Dec 17, 2024$0.1111
  • Jun 11, 2024$0.1114
  • Dec 20, 2023$0.1692
  • Jun 7, 2023$0.0708
  • Jun 9, 2022$0.1359
  • Dec 13, 2021$0.2564
Actions

Metrics

Risk Indicators

Alpha30.80%
Beta1.12x
Sharpe1.29
Sortino2.11
Omega1.24
Calmar3.67
Martin8.66

Profile

About IDNA

The iShares Genomics Immunology and Healthcare ETF seeks to track the investment results of an index composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering.

From its prospectus, filed Nov 28, 2025
Category
Health Care
Expense ratio
0.47%
Fund size
$321M
Inception
Jun 2019